Skip to main content
Fig. 2 | Diabetology & Metabolic Syndrome

Fig. 2

From: 12,13-diHOME and noradrenaline are associated with the occurrence of acute myocardial infarction in patients with type 2 diabetes mellitus

Fig. 2

The 146 differential serum metabolites among control subjects and T2DM patients without or with AMI identified using untargeted metabonomic. a and b, The PCA score plots of differential serum metabolites either in positive or negative model from the untargeted metabonomic analysis. c and d, The OPLS-DA score plots and corresponding validation model of differential serum metabolites either in positive or negative model from the untargeted metabonomic analysis. e, The heatmap showing the levels of 146 differential metabolites. f and g, the differential serum metabolites classified according to the function (f) or category (g). Control: normal control subjects. n = 28; T2DM, patients with type 2 diabetes, n = 30; T2DM + AMI, type 2 diabetes patients with acute myocardial infarction (n = 24)

Back to article page